1-8 of 8
Jonas S. Jutzi
Close
Sort by
Journal Articles

Updated Findings of a Phase II Study of Ruxolitinib Pre-, during- and Post-Hematopoietic Stem Cell Transplantation for Patients with Primary or Secondary Myelofibrosis

Gabriela S. Hobbs, Haesook T. Kim, Suzanne O'Connor, Mark A. Schroeder, Roni Tamari, Sarah A Wall, Areej El-Jawahri, Steven McAfee, Jessica Hem, Patricia Lozano, Jonas S. Jutzi, Ann Mullally, Yi-Bin Chen, Zachariah Defilipp
Journal: Blood
Blood (2023) 142 (Supplement 1): 2103.
https://doi.org/10.1182/blood-2023-178645
Published: 2023
Journal Articles

Two to tango! IL-13 and TGF-β drive myelofibrosis

Jonas S. Jutzi, Ann Mullally
Journal: Blood
Blood (2022) 140 (26): 2767–2768.
https://doi.org/10.1182/blood.2022018859
Published: 2022
Includes: Supplemental data
Journal Articles

Mutant Srsf2 Diminishes Jak2 V617F -Induced Erythrocytosis in Mice and Is Associated with Lower Hemoglobin in Patients with Chronic Phase JAK2 -Mutant MPN

Anna E Marneth, Jonas S. Jutzi, Chulwoo J. Kim, Charles Laurore, Anastasia Tishena, Frederike Kramer, Azucena V. Rocha, Mohammed Wazir, Lachelle D. Weeks, Joan How, Maximilian F. Stahl, Marlise R. Luskin, R. Coleman Lindsley, Olga Pozdnyakova, Timothy A. Graubert, Ann Mullally
Journal: Blood
Blood (2022) 140 (Supplement 1): 1089–1090.
https://doi.org/10.1182/blood-2022-158823
Published: 2022
Journal Articles

Whole-genome CRISPR screening identifies N- glycosylation as a genetic and therapeutic vulnerability in CALR -mutant MPNs

Jonas S. Jutzi, Anna E. Marneth, Michele Ciboddo, Angel Guerra-Moreno, María José Jiménez-Santos, Anastasia Kosmidou, James W. Dressman, Hongyan Liang, Rebecca Hamel, Patricia Lozano, Elisa Rumi, John G. Doench, Jason Gotlib, Anandi Krishnan, Shannon Elf, Fátima Al-Shahrour, Ann Mullally
Journal: Blood
Blood (2022) 140 (11): 1291–1304.
https://doi.org/10.1182/blood.2022015629
Published: 2022
Includes: Supplemental data
Journal Articles

Whole-Genome CRISPR Screening Identifies N -Glycosylation As an Essential Pathway and a Potential Novel Therapeutic Target in CALR -Mutant MPN

Anna E. Marneth, Jonas S. Jutzi, Angel Guerra-Moreno, Michele Ciboddo, María José Jiménez Santos, Anastasia Kosmidou, Rebecca Hamel, Patricia Lozano, Elisa Rumi, John G. Doench, Jason Gotlib, Anandi Krishnan, Shannon Elf, Fatima Al-Shahrour, Ann Mullally
Journal: Blood
Blood (2021) 138 (Supplement 1): 58.
https://doi.org/10.1182/blood-2021-149218
Published: 2021
Journal Articles

Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms

Jan C. Peeken, Jonas S. Jutzi, Julius Wehrle, Christoph Koellerer, Hans F. Staehle, Heiko Becker, Elias Schoenwandt, Thalia S. Seeger, Daniel H. Schanne, Monika Gothwal, Christopher J. Ott, Albert Gründer, Heike L. Pahl
Journal: Blood
Blood (2018) 131 (18): 2065–2073.
https://doi.org/10.1182/blood-2017-10-810622
Published: 2018
Includes: Supplemental data
Journal Articles

ITCH Deficiency Promotes an MPN Phenotype with Eosinophilia, Inflammation, Mislocalization and Overexpression of the Transcription Factor NF-E2

Jonas S. Jutzi, A Gruender, Konrad Aumann, Heike L. Pahl, PhD
Journal: Blood
Blood (2014) 124 (21): 821.
https://doi.org/10.1182/blood.V124.21.821.821
Published: 2014
Journal Articles

Mutations In Transcription Factor NF-E2 Confer Resistance To Interferon Treatment In MPN Patients

Jonas S. Jutzi, Albert Gründer, PhD, Sandra Kaiser, Gorica Nikoloski, Joop H. Jansen, PhD, Heike L. Pahl, PhD
Journal: Blood
Blood (2013) 122 (21): 4096.
https://doi.org/10.1182/blood.V122.21.4096.4096
Published: 2013